ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tumor Immune Cell Therapy Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-28T17280
Home | Market Reports | Health| Health Conditions| Cancer
Global Tumor Immune Cell Therapy Market Research Report 2024
BUY CHAPTERS

Global Tumor Immune Cell Therapy Market Research Report 2024

Code: QYRE-Auto-28T17280
Report
June 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Medinet
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
Legend Biotech

Tumor Immune Cell Therapy Market

Cancer immune cell therapy is a treatment method that activates the function of the patient's own immune cells, thereby enhancing the immune cells' ability to attack cancer and inhibit cancer cells. In actual treatment, we extract immune cells involved in attacking cancer from the patient's blood, cancer tissue, ascites, and pleural effusion, proliferate, activate, and enhance their functions in vitro before returning them to the patient.
The global Tumor Immune Cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Tumor Immune Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Tumor Immune Cell Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Tumor Immune Cell Therapy in Hematological Tumors is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Tumor Immune Cell Therapy include MEDINET Co, Erytech, Seta Clinic Group, Takeda, SBI Holdings, Oxford BioTherapeutics, Fate Therapeutics, Gilead Sciences, Novartis, Osiris, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Tumor Immune Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Immune Cell Therapy.
The Tumor Immune Cell Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Immune Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tumor Immune Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Tumor Immune Cell Therapy Market Report

Report Metric Details
Report Name Tumor Immune Cell Therapy Market
Segment by Type
  • Immune Checkpoint Inhibitors
  • Chimeric Antigen Receptor T-cell Therapy
  • Tumor-Infiltrating Lymphocytes Therapy
  • Cancer Vaccines
  • Bispecific Antibodies
  • Cytokine Therapy
Segment by Application
  • Hematological Tumors
  • Solid Tumors
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MEDINET Co, Erytech, Seta Clinic Group, Takeda, SBI Holdings, Oxford BioTherapeutics, Fate Therapeutics, Gilead Sciences, Novartis, Osiris, Vericel Corporation, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology, Golden Meditech, Guanhao Biotech, Beroni Group, Legend Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Tumor Immune Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor Immune Cell Therapy Market report?

Ans: The main players in the Tumor Immune Cell Therapy Market are MEDINET Co, Erytech, Seta Clinic Group, Takeda, SBI Holdings, Oxford BioTherapeutics, Fate Therapeutics, Gilead Sciences, Novartis, Osiris, Vericel Corporation, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology, Golden Meditech, Guanhao Biotech, Beroni Group, Legend Biotech

What are the Application segmentation covered in the Tumor Immune Cell Therapy Market report?

Ans: The Applications covered in the Tumor Immune Cell Therapy Market report are Hematological Tumors, Solid Tumors

What are the Type segmentation covered in the Tumor Immune Cell Therapy Market report?

Ans: The Types covered in the Tumor Immune Cell Therapy Market report are Immune Checkpoint Inhibitors, Chimeric Antigen Receptor T-cell Therapy, Tumor-Infiltrating Lymphocytes Therapy, Cancer Vaccines, Bispecific Antibodies, Cytokine Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Immune Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Chimeric Antigen Receptor T-cell Therapy
1.2.4 Tumor-Infiltrating Lymphocytes Therapy
1.2.5 Cancer Vaccines
1.2.6 Bispecific Antibodies
1.2.7 Cytokine Therapy
1.3 Market by Application
1.3.1 Global Tumor Immune Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hematological Tumors
1.3.3 Solid Tumors
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tumor Immune Cell Therapy Market Perspective (2019-2030)
2.2 Global Tumor Immune Cell Therapy Growth Trends by Region
2.2.1 Global Tumor Immune Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tumor Immune Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Tumor Immune Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Tumor Immune Cell Therapy Market Dynamics
2.3.1 Tumor Immune Cell Therapy Industry Trends
2.3.2 Tumor Immune Cell Therapy Market Drivers
2.3.3 Tumor Immune Cell Therapy Market Challenges
2.3.4 Tumor Immune Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Immune Cell Therapy Players by Revenue
3.1.1 Global Top Tumor Immune Cell Therapy Players by Revenue (2019-2024)
3.1.2 Global Tumor Immune Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Tumor Immune Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Tumor Immune Cell Therapy Revenue
3.4 Global Tumor Immune Cell Therapy Market Concentration Ratio
3.4.1 Global Tumor Immune Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Immune Cell Therapy Revenue in 2023
3.5 Global Key Players of Tumor Immune Cell Therapy Head office and Area Served
3.6 Global Key Players of Tumor Immune Cell Therapy, Product and Application
3.7 Global Key Players of Tumor Immune Cell Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Immune Cell Therapy Breakdown Data by Type
4.1 Global Tumor Immune Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Tumor Immune Cell Therapy Forecasted Market Size by Type (2025-2030)
5 Tumor Immune Cell Therapy Breakdown Data by Application
5.1 Global Tumor Immune Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Tumor Immune Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tumor Immune Cell Therapy Market Size (2019-2030)
6.2 North America Tumor Immune Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tumor Immune Cell Therapy Market Size by Country (2019-2024)
6.4 North America Tumor Immune Cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tumor Immune Cell Therapy Market Size (2019-2030)
7.2 Europe Tumor Immune Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tumor Immune Cell Therapy Market Size by Country (2019-2024)
7.4 Europe Tumor Immune Cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tumor Immune Cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific Tumor Immune Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tumor Immune Cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Tumor Immune Cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tumor Immune Cell Therapy Market Size (2019-2030)
9.2 Latin America Tumor Immune Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tumor Immune Cell Therapy Market Size by Country (2019-2024)
9.4 Latin America Tumor Immune Cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Immune Cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa Tumor Immune Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tumor Immune Cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Tumor Immune Cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MEDINET Co
11.1.1 MEDINET Co Company Details
11.1.2 MEDINET Co Business Overview
11.1.3 MEDINET Co Tumor Immune Cell Therapy Introduction
11.1.4 MEDINET Co Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.1.5 MEDINET Co Recent Development
11.2 Erytech
11.2.1 Erytech Company Details
11.2.2 Erytech Business Overview
11.2.3 Erytech Tumor Immune Cell Therapy Introduction
11.2.4 Erytech Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.2.5 Erytech Recent Development
11.3 Seta Clinic Group
11.3.1 Seta Clinic Group Company Details
11.3.2 Seta Clinic Group Business Overview
11.3.3 Seta Clinic Group Tumor Immune Cell Therapy Introduction
11.3.4 Seta Clinic Group Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.3.5 Seta Clinic Group Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Tumor Immune Cell Therapy Introduction
11.4.4 Takeda Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.4.5 Takeda Recent Development
11.5 SBI Holdings
11.5.1 SBI Holdings Company Details
11.5.2 SBI Holdings Business Overview
11.5.3 SBI Holdings Tumor Immune Cell Therapy Introduction
11.5.4 SBI Holdings Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.5.5 SBI Holdings Recent Development
11.6 Oxford BioTherapeutics
11.6.1 Oxford BioTherapeutics Company Details
11.6.2 Oxford BioTherapeutics Business Overview
11.6.3 Oxford BioTherapeutics Tumor Immune Cell Therapy Introduction
11.6.4 Oxford BioTherapeutics Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.6.5 Oxford BioTherapeutics Recent Development
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Details
11.7.2 Fate Therapeutics Business Overview
11.7.3 Fate Therapeutics Tumor Immune Cell Therapy Introduction
11.7.4 Fate Therapeutics Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.7.5 Fate Therapeutics Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Tumor Immune Cell Therapy Introduction
11.8.4 Gilead Sciences Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.8.5 Gilead Sciences Recent Development
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Tumor Immune Cell Therapy Introduction
11.9.4 Novartis Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Osiris
11.10.1 Osiris Company Details
11.10.2 Osiris Business Overview
11.10.3 Osiris Tumor Immune Cell Therapy Introduction
11.10.4 Osiris Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.10.5 Osiris Recent Development
11.11 Vericel Corporation
11.11.1 Vericel Corporation Company Details
11.11.2 Vericel Corporation Business Overview
11.11.3 Vericel Corporation Tumor Immune Cell Therapy Introduction
11.11.4 Vericel Corporation Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.11.5 Vericel Corporation Recent Development
11.12 Fujifilm Cellular Dynamics
11.12.1 Fujifilm Cellular Dynamics Company Details
11.12.2 Fujifilm Cellular Dynamics Business Overview
11.12.3 Fujifilm Cellular Dynamics Tumor Immune Cell Therapy Introduction
11.12.4 Fujifilm Cellular Dynamics Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.12.5 Fujifilm Cellular Dynamics Recent Development
11.13 JCR Pharmaceuticals
11.13.1 JCR Pharmaceuticals Company Details
11.13.2 JCR Pharmaceuticals Business Overview
11.13.3 JCR Pharmaceuticals Tumor Immune Cell Therapy Introduction
11.13.4 JCR Pharmaceuticals Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.13.5 JCR Pharmaceuticals Recent Development
11.14 Beike Biotechnology
11.14.1 Beike Biotechnology Company Details
11.14.2 Beike Biotechnology Business Overview
11.14.3 Beike Biotechnology Tumor Immune Cell Therapy Introduction
11.14.4 Beike Biotechnology Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.14.5 Beike Biotechnology Recent Development
11.15 Golden Meditech
11.15.1 Golden Meditech Company Details
11.15.2 Golden Meditech Business Overview
11.15.3 Golden Meditech Tumor Immune Cell Therapy Introduction
11.15.4 Golden Meditech Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.15.5 Golden Meditech Recent Development
11.16 Guanhao Biotech
11.16.1 Guanhao Biotech Company Details
11.16.2 Guanhao Biotech Business Overview
11.16.3 Guanhao Biotech Tumor Immune Cell Therapy Introduction
11.16.4 Guanhao Biotech Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.16.5 Guanhao Biotech Recent Development
11.17 Beroni Group
11.17.1 Beroni Group Company Details
11.17.2 Beroni Group Business Overview
11.17.3 Beroni Group Tumor Immune Cell Therapy Introduction
11.17.4 Beroni Group Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.17.5 Beroni Group Recent Development
11.18 Legend Biotech
11.18.1 Legend Biotech Company Details
11.18.2 Legend Biotech Business Overview
11.18.3 Legend Biotech Tumor Immune Cell Therapy Introduction
11.18.4 Legend Biotech Revenue in Tumor Immune Cell Therapy Business (2019-2024)
11.18.5 Legend Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Medinet
Erytech
Seta Clinic Group
Takeda
SBI Holdings
Oxford BioTherapeutics
Fate Therapeutics
Gilead Sciences
Novartis
Osiris
Vericel Corporation
Fujifilm Cellular Dynamics
JCR Pharmaceuticals
Beike Biotechnology
Golden Meditech
Guanhao Biotech
Beroni Group
Legend Biotech
List of Tables
 Table 1. Global Tumor Immune Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Immune Checkpoint Inhibitors
 Table 3. Key Players of Chimeric Antigen Receptor T-cell Therapy
 Table 4. Key Players of Tumor-Infiltrating Lymphocytes Therapy
 Table 5. Key Players of Cancer Vaccines
 Table 6. Key Players of Bispecific Antibodies
 Table 7. Key Players of Cytokine Therapy
 Table 8. Global Tumor Immune Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 9. Global Tumor Immune Cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 10. Global Tumor Immune Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
 Table 11. Global Tumor Immune Cell Therapy Market Share by Region (2019-2024)
 Table 12. Global Tumor Immune Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 13. Global Tumor Immune Cell Therapy Market Share by Region (2025-2030)
 Table 14. Tumor Immune Cell Therapy Market Trends
 Table 15. Tumor Immune Cell Therapy Market Drivers
 Table 16. Tumor Immune Cell Therapy Market Challenges
 Table 17. Tumor Immune Cell Therapy Market Restraints
 Table 18. Global Tumor Immune Cell Therapy Revenue by Players (2019-2024) & (US$ Million)
 Table 19. Global Tumor Immune Cell Therapy Market Share by Players (2019-2024)
 Table 20. Global Top Tumor Immune Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Immune Cell Therapy as of 2023)
 Table 21. Ranking of Global Top Tumor Immune Cell Therapy Companies by Revenue (US$ Million) in 2023
 Table 22. Global 5 Largest Players Market Share by Tumor Immune Cell Therapy Revenue (CR5 and HHI) & (2019-2024)
 Table 23. Global Key Players of Tumor Immune Cell Therapy, Headquarters and Area Served
 Table 24. Global Key Players of Tumor Immune Cell Therapy, Product and Application
 Table 25. Global Key Players of Tumor Immune Cell Therapy, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Tumor Immune Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
 Table 28. Global Tumor Immune Cell Therapy Revenue Market Share by Type (2019-2024)
 Table 29. Global Tumor Immune Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 30. Global Tumor Immune Cell Therapy Revenue Market Share by Type (2025-2030)
 Table 31. Global Tumor Immune Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
 Table 32. Global Tumor Immune Cell Therapy Revenue Market Share by Application (2019-2024)
 Table 33. Global Tumor Immune Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 34. Global Tumor Immune Cell Therapy Revenue Market Share by Application (2025-2030)
 Table 35. North America Tumor Immune Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. North America Tumor Immune Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 37. North America Tumor Immune Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Europe Tumor Immune Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 39. Europe Tumor Immune Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 40. Europe Tumor Immune Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 41. Asia-Pacific Tumor Immune Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 42. Asia-Pacific Tumor Immune Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
 Table 43. Asia-Pacific Tumor Immune Cell Therapy Market Size by Region (2025-2030) & (US$ Million)
 Table 44. Latin America Tumor Immune Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 45. Latin America Tumor Immune Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 46. Latin America Tumor Immune Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 47. Middle East & Africa Tumor Immune Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 48. Middle East & Africa Tumor Immune Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
 Table 49. Middle East & Africa Tumor Immune Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
 Table 50. MEDINET Co Company Details
 Table 51. MEDINET Co Business Overview
 Table 52. MEDINET Co Tumor Immune Cell Therapy Product
 Table 53. MEDINET Co Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 54. MEDINET Co Recent Development
 Table 55. Erytech Company Details
 Table 56. Erytech Business Overview
 Table 57. Erytech Tumor Immune Cell Therapy Product
 Table 58. Erytech Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 59. Erytech Recent Development
 Table 60. Seta Clinic Group Company Details
 Table 61. Seta Clinic Group Business Overview
 Table 62. Seta Clinic Group Tumor Immune Cell Therapy Product
 Table 63. Seta Clinic Group Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 64. Seta Clinic Group Recent Development
 Table 65. Takeda Company Details
 Table 66. Takeda Business Overview
 Table 67. Takeda Tumor Immune Cell Therapy Product
 Table 68. Takeda Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 69. Takeda Recent Development
 Table 70. SBI Holdings Company Details
 Table 71. SBI Holdings Business Overview
 Table 72. SBI Holdings Tumor Immune Cell Therapy Product
 Table 73. SBI Holdings Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 74. SBI Holdings Recent Development
 Table 75. Oxford BioTherapeutics Company Details
 Table 76. Oxford BioTherapeutics Business Overview
 Table 77. Oxford BioTherapeutics Tumor Immune Cell Therapy Product
 Table 78. Oxford BioTherapeutics Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 79. Oxford BioTherapeutics Recent Development
 Table 80. Fate Therapeutics Company Details
 Table 81. Fate Therapeutics Business Overview
 Table 82. Fate Therapeutics Tumor Immune Cell Therapy Product
 Table 83. Fate Therapeutics Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 84. Fate Therapeutics Recent Development
 Table 85. Gilead Sciences Company Details
 Table 86. Gilead Sciences Business Overview
 Table 87. Gilead Sciences Tumor Immune Cell Therapy Product
 Table 88. Gilead Sciences Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 89. Gilead Sciences Recent Development
 Table 90. Novartis Company Details
 Table 91. Novartis Business Overview
 Table 92. Novartis Tumor Immune Cell Therapy Product
 Table 93. Novartis Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 94. Novartis Recent Development
 Table 95. Osiris Company Details
 Table 96. Osiris Business Overview
 Table 97. Osiris Tumor Immune Cell Therapy Product
 Table 98. Osiris Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 99. Osiris Recent Development
 Table 100. Vericel Corporation Company Details
 Table 101. Vericel Corporation Business Overview
 Table 102. Vericel Corporation Tumor Immune Cell Therapy Product
 Table 103. Vericel Corporation Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 104. Vericel Corporation Recent Development
 Table 105. Fujifilm Cellular Dynamics Company Details
 Table 106. Fujifilm Cellular Dynamics Business Overview
 Table 107. Fujifilm Cellular Dynamics Tumor Immune Cell Therapy Product
 Table 108. Fujifilm Cellular Dynamics Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 109. Fujifilm Cellular Dynamics Recent Development
 Table 110. JCR Pharmaceuticals Company Details
 Table 111. JCR Pharmaceuticals Business Overview
 Table 112. JCR Pharmaceuticals Tumor Immune Cell Therapy Product
 Table 113. JCR Pharmaceuticals Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 114. JCR Pharmaceuticals Recent Development
 Table 115. Beike Biotechnology Company Details
 Table 116. Beike Biotechnology Business Overview
 Table 117. Beike Biotechnology Tumor Immune Cell Therapy Product
 Table 118. Beike Biotechnology Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 119. Beike Biotechnology Recent Development
 Table 120. Golden Meditech Company Details
 Table 121. Golden Meditech Business Overview
 Table 122. Golden Meditech Tumor Immune Cell Therapy Product
 Table 123. Golden Meditech Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 124. Golden Meditech Recent Development
 Table 125. Guanhao Biotech Company Details
 Table 126. Guanhao Biotech Business Overview
 Table 127. Guanhao Biotech Tumor Immune Cell Therapy Product
 Table 128. Guanhao Biotech Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 129. Guanhao Biotech Recent Development
 Table 130. Beroni Group Company Details
 Table 131. Beroni Group Business Overview
 Table 132. Beroni Group Tumor Immune Cell Therapy Product
 Table 133. Beroni Group Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 134. Beroni Group Recent Development
 Table 135. Legend Biotech Company Details
 Table 136. Legend Biotech Business Overview
 Table 137. Legend Biotech Tumor Immune Cell Therapy Product
 Table 138. Legend Biotech Revenue in Tumor Immune Cell Therapy Business (2019-2024) & (US$ Million)
 Table 139. Legend Biotech Recent Development
 Table 140. Research Programs/Design for This Report
 Table 141. Key Data Information from Secondary Sources
 Table 142. Key Data Information from Primary Sources
 Table 143. Authors List of This Report


List of Figures
 Figure 1. Tumor Immune Cell Therapy Picture
 Figure 2. Global Tumor Immune Cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Tumor Immune Cell Therapy Market Share by Type: 2023 VS 2030
 Figure 4. Immune Checkpoint Inhibitors Features
 Figure 5. Chimeric Antigen Receptor T-cell Therapy Features
 Figure 6. Tumor-Infiltrating Lymphocytes Therapy Features
 Figure 7. Cancer Vaccines Features
 Figure 8. Bispecific Antibodies Features
 Figure 9. Cytokine Therapy Features
 Figure 10. Global Tumor Immune Cell Therapy Market Size by Application (2024-2030) & (US$ Million)
 Figure 11. Global Tumor Immune Cell Therapy Market Share by Application: 2023 VS 2030
 Figure 12. Hematological Tumors Case Studies
 Figure 13. Solid Tumors Case Studies
 Figure 14. Tumor Immune Cell Therapy Report Years Considered
 Figure 15. Global Tumor Immune Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 16. Global Tumor Immune Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 17. Global Tumor Immune Cell Therapy Market Share by Region: 2023 VS 2030
 Figure 18. Global Tumor Immune Cell Therapy Market Share by Players in 2023
 Figure 19. Global Top Tumor Immune Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Immune Cell Therapy as of 2023)
 Figure 20. The Top 10 and 5 Players Market Share by Tumor Immune Cell Therapy Revenue in 2023
 Figure 21. North America Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. North America Tumor Immune Cell Therapy Market Share by Country (2019-2030)
 Figure 23. United States Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Canada Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Europe Tumor Immune Cell Therapy Market Share by Country (2019-2030)
 Figure 27. Germany Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. France Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. U.K. Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Italy Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Russia Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Nordic Countries Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Asia-Pacific Tumor Immune Cell Therapy Market Share by Region (2019-2030)
 Figure 35. China Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Japan Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. South Korea Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Southeast Asia Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. India Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Australia Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Latin America Tumor Immune Cell Therapy Market Share by Country (2019-2030)
 Figure 43. Mexico Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Brazil Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East & Africa Tumor Immune Cell Therapy Market Share by Country (2019-2030)
 Figure 47. Turkey Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. UAE Tumor Immune Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. MEDINET Co Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 51. Erytech Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 52. Seta Clinic Group Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 53. Takeda Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 54. SBI Holdings Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 55. Oxford BioTherapeutics Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 56. Fate Therapeutics Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 57. Gilead Sciences Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 58. Novartis Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 59. Osiris Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 60. Vericel Corporation Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 61. Fujifilm Cellular Dynamics Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 62. JCR Pharmaceuticals Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 63. Beike Biotechnology Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 64. Golden Meditech Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 65. Guanhao Biotech Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 66. Beroni Group Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 67. Legend Biotech Revenue Growth Rate in Tumor Immune Cell Therapy Business (2019-2024)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immuno Cell Therapy Market Research Report 2024
Global Immune Cell Therapy Drugs Market Research Report 2025
Global Cell Immunotherapy Platform Market Research Report 2024
Natural Killer NK Cell Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global NK Cell Therapy Market Insights Forecast to 2030
Global Cancer Immunosuppressant Treatment Market Research Report 2024
Global Cancer Immuno Personalized Medicine Market Research Report 2024
Global Cancer Immunotherapy Drugs Market Research Report 2024
Global Immunosuppressants in Cancer Therapy Market Research Report 2024
Global Immunotherapy Drugs Market Research Report 2024
Global Immuno oncology Therapy Market Insights Forecast to 2030
Global Immunocell Therapy Market Insights Forecast to 2030
Global Natural Killer Cell Therapy Market Insights Forecast to 2030
Global Adoptive Cell Therapy Market Insights Forecast to 2030
Global Natural Killer Cells Therapeutics Market Insights Forecast to 2030
Global Natural Killer Cell Therapeutics Market Research Report 2024
Global T Cell Immunotherapy Market Research Report 2025
Engineered Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Therapy Market Insights Forecast to 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions